Naloxone-resistant respiratory depression and neurological eye symptoms after intrathecal morphine.
We describe a case of neurological symptoms after the intrathecal use of an opioid. These symptoms were not reversible by the use of an opioid-antagonist.
Krenn
H
H
Department of Anesthesia and Intensive Care Medicine, City of Vienna Hospital Lainz, Vienna, Austria.
Jellinek
H
H
Haumer
H
H
Oczenski
W
W
Fitzgerald
R
R
D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D000932:Antiemetics / Q000009:adverse effects; D003864:Depression, Chemical; D004347:Drug Interactions; D004351:Drug Resistance; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008787:Metoclopramide / Q000009:adverse effects; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects*; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D010149:Postoperative Pain / Q000188:drug therapy*; D012119:Respiration / Q000187:drug effects*
D000701:Analgesics, Opioid; D000932:Antiemetics; D009292:Narcotic Antagonists; D009270:Naloxone; D009020:Morphine; D008787:Metoclopramide